Compare Inovio Pharmaceuticals Inc (INO) vs Norfolk Southern Corporation (NSC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Inovio Pharmaceuticals Inc vs Norfolk Southern Corporation — how do they compare? Inovio Pharmaceuticals Inc trades at $1.08 (market cap $89.27M), while Norfolk Southern Corporation trades at $333.48 (market cap $75.23B). The key difference: Norfolk Southern Corporation is far larger — about 842.7× Inovio Pharmaceuticals Inc's market cap, and Norfolk Southern Corporation pays a 1.61% dividend while Inovio Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| INO | NSC | |
|---|---|---|
Market Cap | $89.27M | $75.23B |
Sector | Health | Technology |
52-Week High | $2.87 | $340.16 |
52-Week Low | $1.05 | $272.35 |
Enterprise Value | $60.28M | $90.99B |
Dividend Yield | — | 1.61% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Inovio Pharmaceuticals Inc
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →About Norfolk Southern Corporation
Norfolk Southern Corporation is a major North American railroad company operating one of the largest freight rail networks in the eastern United States. The company transports a diverse range of commodities, including coal, intermodal containers, and various industrial products. NSC is a critical link in the nation's supply chain, providing efficient, long-haul transportation services to and from ports and industrial centers.
Read more on NSC →
